Health Economics and Outcomes Research (HEOR)

Our well-wishers always ask this question- will Eckrox ever slow down on their expansion? For a change, we would like to disappoint them. Our expansion plans are in our DNA( and logically our growth too) which is dynamic to the core.

We realised the importance of the following in the Medical and Pharmaceutical world on a global level:

  • Drug safety (Pharmacovigilance ),
  • Medical writing,
  • Individual case safety report (ICSR) management,
  • Health Economics and Outcomes Research (HEOR),
  • Risk management,
  • Literature surveillance.

Our competence in HEOR

We cater to the many global leaders with our superb consultancy services. Here below are our competence in the Health Economics and Outcomes Research (HEOR) in brief.

We fully understand product value in healthcare and its potential in real-world clinical practices. The various factors like the following fields shall impact on the key players significantly as far as product commercialisation is concerned.

  • Pricing
  • Regulations
  • Health care criticality
  • Technological advancement

Service catalogue

These Service catalogues shall be crucial in Health Economics and Outcomes Research (HEOR)

  • Burden-of-Illness Research
  • Comparative Economic Evaluation Research
  • Comparative Effectiveness Research
  • Indirect or Network Meta-analysis
  • Clinical Research & Study Design
  • Patient-Reported Outcomes
  • Unmet Medical Need Research

Cost and disbursement in HEOR

The seamless method of generating evidence of the value of new interventions for reimbursement agencies and local health care payers is so far lagging behind. Now with the advent HEOR the entire scenario is changed for good. Now the advantage touches health care professionals as well as the patient alike. The other players involved are authorities and the voluntary sector as health economics is gaining importance all over the globe. The Strategic Leadership Team actively propagated under this scheme is meant to encourage staff training and development.

More in the anvil

We are also involved with

  • Economic Modelling,
  • Economic evaluations on a varying range of healthcare interventions,
  • Global health technology assessment (HTA) models,
  • Early modelling,
  • Budget impact analysis,
  • The burden of illness studies,
  • Model critical validation,
  • Model adaptations,

The key area Eckrox are concentrating are

  • Pharmaceuticals;
  • Medical devices;
  • Diagnostic technologies;
  • Surgical procedures;
  • Public health interventions.

Health Economics & Outcomes Research (HEOR) involves multiple players

To cope up this numerous player scenario in the field we have sharpened our comprehensive research capabilities, defined by cutting-edge methodologies.

We have developed various types of models to meet needs of the client, including budget impact models to assess the economic implications to compare a client’s drugs to comparators.

  • new formulary cost-minimisation,
  • cost-utility, and
  • cost-effectiveness

Also, we have plunged deep into 

Comparative simple cost calculators to evaluate the costs of treatments and costs of adverse events. That includes but not limited to the following:

  • Burden-of-Illness Research
  • Effectiveness Research
  • Patient-Reported Outcomes
  • Clinical Research & Study Design
  • Personalized Medicine
  • Rare Disease & Orphan Drug Research
  • Litigation Services
  • Modelling & Analytics

On the outset, let us confess that our journey for our ambition, excellence and expansion has no limits.


Office contact




Make a Video Call


Ekrocx_Tech Technologies


contact us